OSI Systems Reports Third Quarter Fiscal 2014 Financial Results
-
Q3 Earnings Per Share
-
Non-GAAP of
$0.70 -
GAAP of
$0.23
-
Non-GAAP of
- Record Adjusted EBITDA (13% increase in Q3 and 37% increase for nine months)
-
Q3 Free Cash Flow of
$42 million - Company's fiscal 2014 guidance: Revenue (11% - 15% growth) and EPS (12% - 19% growth)
"During the third quarter, we produced outstanding cash flow and
generated record Adjusted EBITDA. Our earnings, however, fell short of
the third quarter in the prior year primarily due to much higher
depreciation in the current year as a result of the ramp-up of our
Mexican turnkey operations, and several significant sales opportunities
that slipped to our fourth quarter. We believe we are positioned to
deliver very strong fourth quarter results," said
The Company reported revenues of
For the nine months ended
During the third quarter, the Company made certain tax elections related
to the turnkey program in
As of
Fiscal Year 2014 Outlook
The Company is reiterating its sales guidance for fiscal 2014 of
New Presentation of Non-GAAP Financial Measure; Non-GAAP Figures
This earnings release includes a presentation of Adjusted EBITDA, a new
non-GAAP financial measure for the Company. Adjusted EBITDA is presented
as a supplemental measure of the Company's financial performance that we
believe is useful to investors because the excluded items may vary
significantly in timing or amounts and/or may obscure trends useful in
evaluating and comparing the Company's operating activities across
reporting periods. Its introduction coincides with the Company's shift
to increased levels of capital intensive turnkey screening services and
the accompanying increased depreciation. Adjusted EBITDA is defined as
net income, plus net interest expense, provision for income taxes and
depreciation and amortization, as further adjusted to eliminate the
impact of stock-based compensation, and impairment, restructuring and
other charges. Not all companies use identical calculations and,
accordingly, the Company's presentation of Adjusted EBITDA may not be
comparable to other similarly titled measures of other companies.
Adjusted EBITDA is not a recognized term under accounting principles
generally accepted in
Discussion of adjustments to arrive at non-GAAP net income and earnings
per share figures and Adjusted EBITDA per share for the three and nine
months ended
See the reconciliations of GAAP to non-GAAP net income and earnings per share, and net income to Adjusted EBITDA in the accompanying tables.
Conference Call Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, Section
27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking statements
relate to the Company's current expectations, beliefs, projections and
similar expressions concerning matters that are not historical facts and
are not guarantees of future performance. Forward-looking
statements involve uncertainties, risks, assumptions and contingencies,
many of which are outside the Company's control and which may cause
actual results to differ materially from those described in or implied
by any forward-looking statement. Such statements include, but are not
limited to, information provided regarding expected revenues and
earnings in fiscal 2014, future growth in the Company's Security
Division and the development and launch of new products in the Company's
Healthcare Division. In addition, the Company could be exposed to a
variety of negative consequences as a result of delays related to the
award of domestic and international contracts; delays in customer
programs; unanticipated impacts of sequestration and other provisions of
the Budget Control Act of 2011 as modified by the Bipartisan Budget Act
of 2013; changes in domestic and foreign government spending, budgetary,
procurement and trade policies adverse to our businesses; market
acceptance of our new and existing technologies, products and services;
our ability to win new business and convert any orders received to
sales within the fiscal year in accordance with our annual operating
plan; one or more enforcement actions in respect of any noncompliance
with laws and regulations including export control and environmental
regulations and the matters that are the subject of some or all of the
Company's ongoing investigations and compliance reviews, including
contract and regulatory compliance matters with the
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(in thousands, except per share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2013 | 2014 | 2013 | 2014 | |||||||||||||
Revenues | $ | 198,409 | $ | 203,956 | $ | 574,152 | $ | 646,638 | ||||||||
Cost of goods sold | 126,571 | 133,449 | 370,871 | 427,246 | ||||||||||||
Gross profit | 71,838 | 70,507 | 203,281 | 219,392 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative expenses | 37,752 | 39,399 | 114,506 | 127,169 | ||||||||||||
Research and development | 12,386 | 10,579 | 35,560 | 32,774 | ||||||||||||
Impairment, restructuring and other charges | 2,286 | 2,507 | 5,009 | 8,925 | ||||||||||||
Total operating expenses | 52,424 | 52,485 | 155,075 | 168,868 | ||||||||||||
Income from operations | 19,414 | 18,022 | 48,206 | 50,524 | ||||||||||||
Interest expense and other, net | 1,341 | 1,370 | 3,823 | 4,343 | ||||||||||||
Income before income taxes | 18,073 | 16,652 | 44,383 | 46,181 | ||||||||||||
Provision for income taxes | 4,544 | 11,851 | 12,094 | 20,413 | ||||||||||||
Net income | $ | 13,529 | $ | 4,801 | $ | 32,289 | $ | 25,768 | ||||||||
Diluted earnings per share | $ | 0.66 | $ | 0.23 | $ | 1.57 | $ | 1.25 | ||||||||
Weighted average shares outstanding - diluted | 20,555 | 20,548 | 20,578 | 20,585 | ||||||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||||||
(in thousands) |
||||||||||||
(Unaudited) |
||||||||||||
|
|
|||||||||||
Assets | ||||||||||||
Cash and cash equivalents | $ | 34,697 | $ | 39,848 | ||||||||
Accounts receivable, net | 206,817 | 142,806 | ||||||||||
Inventories | 206,213 | 239,026 | ||||||||||
Other current assets | 78,972 | 93,932 | ||||||||||
Total current assets | 526,699 | 515,612 | ||||||||||
Non-current assets | 393,097 | 424,135 | ||||||||||
Total Assets | $ | 919,796 | $ | 939, 747 | ||||||||
Liabilities and Stockholders' Equity | ||||||||||||
Bank lines of credit | $ | 59,000 | $ | 22,000 | ||||||||
Current portion of long-term debt | 1,797 | 2,779 | ||||||||||
Accounts payable and accrued expenses | 123,660 | 95,443 | ||||||||||
Deferred revenues | 18,131 | 62,940 | ||||||||||
Other current liabilities | 78,825 | 83,089 | ||||||||||
Total current liabilities | 281,413 | 266,251 | ||||||||||
Long-term debt | 10,673 | 10,847 | ||||||||||
Advances from customers | 75,000 | 56,250 | ||||||||||
Deferred income taxes | 30,248 | 57,163 | ||||||||||
Other long-term liabilities | 44,011 | 47,489 | ||||||||||
Total liabilities | 441,345 | 438,000 | ||||||||||
Total stockholders' equity | 478,451 | 501,747 | ||||||||||
Total Liabilities and Equity | $ | 919,796 | $ | 939,747 | ||||||||
SEGMENT INFORMATION | ||||||||||||||||||||
(in thousands) |
||||||||||||||||||||
(unaudited) |
||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||
2013 | 2014 | 2013 | 2014 | |||||||||||||||||
Revenues - by |
||||||||||||||||||||
|
$ | 99,840 | $ | 95,007 | $ | 274,619 | $ | 298,748 | ||||||||||||
|
51,357 | 52,188 | 159,052 | 161,081 | ||||||||||||||||
Optoelectronics and |
54,761 | 66,331 | 169,185 | 214,000 | ||||||||||||||||
Intersegment revenues elimination | (7,549 | ) | (9,570 | ) | (28,704 | ) | (27,191 | ) | ||||||||||||
Total | $ | 198,409 | $ | 203,956 | $ | 574,152 | $ | 646,638 | ||||||||||||
Operating income (loss) - by |
||||||||||||||||||||
|
$ | 16,179 | $ | 14,213 | $ | 29,251 | $ | 40,984 | ||||||||||||
|
3,593 | 4,084 | 14,389 | 11,312 | ||||||||||||||||
Optoelectronics and |
3,271 | 3,414 | 13,561 | 10,300 | ||||||||||||||||
Corporate (4) | (4,017 | ) | (3,488 | ) | (9,704 | ) | (11,888 | ) | ||||||||||||
Eliminations | 388 | (201 | ) | 709 | (184 | ) | ||||||||||||||
Total | $ | 19,414 | $ | 18,022 | $ | 48,206 | $ | 50,524 |
(1) |
Includes impairment, restructuring and other charges of |
|
(2) |
Includes restructuring and other charges of |
|
(3) |
Includes restructuring and other charges of |
|
(4) |
Includes restructuring and other charges of |
|
Reconciliation of GAAP to Non-GAAP Net Income and Earnings Per Share | ||||||||||||||||||||||||||||||||
(in thousands, except earnings per share data) |
||||||||||||||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
2013 | 2014 | 2013 | 2014 | |||||||||||||||||||||||||||||
Net |
EPS |
Net |
EPS |
Net |
EPS |
Net |
EPS | |||||||||||||||||||||||||
GAAP basis | $ | 13,529 | $ | 0.66 | $ | 4,801 | $ | 0.23 | $ | 32,289 | $ | 1.57 | $ | 25,768 | $ | 1.25 | ||||||||||||||||
Impairment, restructuring and other charges, net of tax | 1,711 | 0.08 | 1,873 | 0.10 | 3,644 | 0.18 | 6,456 | 0.32 | ||||||||||||||||||||||||
Impact from election to accelerate depreciation for tax purposes | -- | -- | 7,638 | 0.37 |
-- |
-- |
7,638 | 0.37 | ||||||||||||||||||||||||
Non-GAAP basis | $ | 15,240 | $ | 0.74 | $ | 14,312 | $ | 0.70 | $ | 35,933 | $ | 1.75 | $ | 39,862 | $ | 1.94 | ||||||||||||||||
Reconciliation of Net Income to Adjusted EBITDA | ||||||||||||||||
(in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2013 | 2014 | 2013 | 2014 | |||||||||||||
Net income | $ | 13,529 | $ | 4,801 | $ | 32,289 | $ | 25,768 | ||||||||
Interest expense, net | 1,341 | 1,370 | 3,823 | 4,343 | ||||||||||||
Provision for income taxes | 4,544 | 11,851 | 12,094 | 20,413 | ||||||||||||
Depreciation and amortization | 7,063 | 13,608 | 17,872 | 40,024 | ||||||||||||
EBITDA | 26,477 | 31,630 | 66,078 | 90,548 | ||||||||||||
Stock-based compensation | 4,336 | 3,254 | 11,482 | 13,975 | ||||||||||||
Impairment, restructuring and other charges | 2,286 | 2,507 | 5,009 | 8,925 | ||||||||||||
Adjusted EBITDA | $ | 33,099 | $ | 37,391 | $ | 82,569 | $ | 113,448 |
Vice
President, Business Development
avashishat@osi-systems.com
Source:
News Provided by Acquire Media